These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of urethan induced lung tumour growth in strain A mice by 5-methyl cytidine. Theiss JC Cytobios; 1980; 29(115-116):159-63. PubMed ID: 7471817 [TBL] [Abstract][Full Text] [Related]
3. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518 [TBL] [Abstract][Full Text] [Related]
5. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127 [TBL] [Abstract][Full Text] [Related]
6. Relationship of lung adenoma prevalence and growth rate to acute urethan dose and target cell number. Dourson ML; O'Flaherty EJ J Natl Cancer Inst; 1982 Oct; 69(4):851-7. PubMed ID: 6956762 [TBL] [Abstract][Full Text] [Related]
7. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. Malkinson AM; Beer DS J Natl Cancer Inst; 1983 May; 70(5):931-6. PubMed ID: 6573537 [TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. LoRusso P; Wozniak AJ; Polin L; Capps D; Leopold WR; Werbel LM; Biernat L; Dan ME; Corbett TH Cancer Res; 1990 Aug; 50(16):4900-5. PubMed ID: 2165850 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the tissue-specific lung adhesive factor on the urethane induction of pulmonary adenomas in mice]. Modianova EA; Malenkov AG; Shabad LM Biull Eksp Biol Med; 1977 Aug; 84(8):193-6. PubMed ID: 907823 [TBL] [Abstract][Full Text] [Related]
12. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050 [TBL] [Abstract][Full Text] [Related]
13. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma. Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708 [TBL] [Abstract][Full Text] [Related]
16. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
17. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Taetle R; Rosen F; Abramson I; Venditti J; Howell S Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435 [TBL] [Abstract][Full Text] [Related]